Diffuse interstitial lung diseases in association with connective tissue diseases

被引:0
作者
Koller, HK [1 ]
Burghuber, OC [1 ]
机构
[1] Otto Wagner Spital, Pulmol Zentrum Stadt Wien, Lungenabt Interne 1, Boltzmann Inst Chron Obstrukt Lungenerkrankungen, A-1140 Vienna, Austria
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2003年 / 62卷 / 02期
关键词
interstitial lung diseases; connective tissue diseases; lung fibrosis;
D O I
10.1007/s00393-003-0485-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article gives a comprehensive overview of diffuse interstitial lung diseases especially those associated with connective tissue diseases. Interstitial lung diseases (ILD) represent a heterogenous group of diseases of very different and partially unknown etiologies. Therefore, an exact classification of the ILD is difficult. ILDs are rarely seen in clinical practice and often lead to diagnostic problems. Diagnostic procedures require the patient's history, physical examination, serological-immunological and routine laboratory tests, pulmonary function testing, chest Xray and high-resolution CT scan, bronchioloalveolar lavage (BAL) and bioptic procedures. The diagnostic approach to ILD requires an intensive multidisciplinary cooperation to offer early and effective therapeutic regimens.
引用
收藏
页码:122 / 135
页数:14
相关论文
共 46 条
  • [1] VISCERAL IMPROVEMENT FOLLOWING COMBINED PLASMAPHERESIS AND IMMUNOSUPPRESSIVE DRUG-THERAPY IN PROGRESSIVE SYSTEMIC-SCLEROSIS
    AKESSON, A
    WOLLHEIM, FA
    THYSELL, H
    GUSTAFSON, T
    FORSBERG, L
    PAHLM, O
    WOLLMER, P
    AKESSON, B
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1988, 17 (05) : 313 - 323
  • [2] [Anonymous], 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]
  • [3] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial
    Badesch, DB
    Tapson, VF
    McGoon, MD
    Brundage, BH
    Rubin, LJ
    Wigley, FM
    Rich, S
    Barst, RJ
    Barrett, PS
    Kral, KM
    Jöbsis, MM
    Loyd, JE
    Murali, S
    Frost, A
    Girgis, R
    Bourge, RC
    Ralph, DD
    Elliott, CG
    Hill, NS
    Langleben, D
    Schilz, RJ
    McLaughlin, VV
    Robbins, IM
    Groves, BM
    Shapiro, S
    Medsger, TA
    Gaine, SP
    Horn, E
    Decker, JC
    Knobil, K
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) : 425 - +
  • [4] THE PLEUROPULMONARY MANIFESTATIONS OF ANKYLOSING-SPONDYLITIS
    BOUSHEA, DK
    SUNDSTROM, WR
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1989, 18 (04) : 277 - 281
  • [5] PULMONARY WEGENERS GRANULOMATOSIS - A CLINICAL AND IMAGING STUDY OF 77 CASES
    CORDIER, JF
    VALEYRE, D
    GUILLEVIN, L
    LOIRE, R
    BRECHOT, JM
    [J]. CHEST, 1990, 97 (04) : 906 - 912
  • [6] THE EPIDEMIOLOGY OF INTERSTITIAL LUNG-DISEASES
    COULTAS, DB
    ZUMWALT, RE
    BLACK, WC
    SOBONYA, RE
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (04) : 967 - 972
  • [7] Cushley MJ, 1999, THORAX, V54, pS1
  • [8] Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis - Methotrexate versus trimethoprim/sulfamethoxazole
    deGroot, K
    ReinholdKeller, E
    Tatsis, E
    Paulsen, J
    Heller, M
    Nolle, B
    Gross, WL
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (12): : 2052 - 2061
  • [9] Interstitial lung disease in primary Sjogren's syndrome - Clinical-pathological evaluation and response to treatment
    Deheinzelin, D
    Capelozzi, VL
    Kairalla, RA
    Barbas, JV
    Saldiva, PHN
    deCarvalho, CRR
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) : 794 - 799
  • [10] Denton CP, 1997, BRIT J RHEUMATOL, V36, P239